LinkBack URL
About LinkBacks
Reply With QuoteHow certain are you that the news is def coming tom after hours. Also will it be good? Spunk I am not doubting you I actually think ur great at these money plays, I am just curious. I followed ur advice on CrxxOriginally Posted by Spunk
OTC:PVCT - Provectus Pharmaceuticals
OTC:PVCT. Investment firm will be bringout key news pertaining to the companies drugs , expect volume to increase and PPS to increase...guys take your possitions tommorow PR news coming after hours.
Last edited by FavStocks; 09-17-2009 at 12:51 AM. Reason: Updated Title with company name
How certain are you that the news is def coming tom after hours. Also will it be good? Spunk I am not doubting you I actually think ur great at these money plays, I am just curious. I followed ur advice on Crxx
apparently there is some news that an article will be written on this company giving it some more exposure. yesterdays volume was very high and today was higher than usual but significantly lower than yesterdays. perhaps the increase volume and awareness can drive it higher?
Stockshaven investment
Will definately be advertising the key attributes of this company, I have learnt after IMGG did its thing today ........stockshaven was behind that PR work....its only natural to get in on their next company before the PR comes out.
there article is out
Taking Cancer Treatment to a New Level (OTC:PVCT) |
lets hope to see some gains tommorrow
i don't know about this. no real volume. the article doesn't seem to have made much impact.
Spunk,
Do you still follow PVCT? It seems to be doing pretty well during this stock market's correction. The volume is kind of low. With all the news below, I think it may attract more investors/traders. If that happens, this may pop.
http://finance.yahoo.com/news/Provec....html?x=0&.v=1
Daily Review 5/21/2010 | Biotech Stocks - Chasing the Alpha
http://finance.yahoo.com/news/SCIA-A....html?x=0&.v=1
Pvct
I find this also about PVCT.
Very interesting.
Provectus (PVCT.OB)
Provectus (in the same industry as Dendreon) is focused on the development of cancer and psoriasis treatment based on the Rose Bengal compound. It's looking strong ahead of key clinical trials and ahead of the ASCO conference.
Here's what's really exciting. According to the company, "Rose Bengal is a red dye that was previously used to test for corneal scratches because it is preferentially absorbed by damaged cells. Provectus found that a highly specialized version of this dye is also absorbed in irregular or damaged cancerous cells."
"As the cancerous cells continue to take in more and more PV-10, they begin to rupture and eventually go into cell necrosis (death). The entire process also occurs without any radiation, which gives the treatment a substantial edge over existing treatments with side-effects."
Posting Permissions 
